News & Updates
This Tuesday, IBM announced that faculty from Harvard Medical School and Brigham & Women’s Hospital will use IBM business analytics technology to examine the effectiveness of prescription drugs and their potential safety issues. Using an IBM Netezza data warehouse appliance (acquired by IBM six months ago), the research team will expand its studies to analyze data from millions of de-identified patient records with the aim to develop new data-intensive drug safety research methods. Dr. Schneeweiss is the principal investigator of the AHRQ-funded DEcIDE Methods Center and Co-Chair of the Methods Core of the FDA-funded Mini Sentinel project. You can read the full press release here.
WellApps, winner of the Health 2.0 NYC Competition, shares their case study on the potential value of patient collected data. In posting about engaged patients using GI Monitor, a mobile symptom-tracking platform currently being used by thousands of IBD patients, WellApps hopes to stimulate more discussion around the use of ODL data (Observations of Daily Living). You can comment here and watch a brief video featuring our friend, WellApps CEO and Co-Founder Brett Shamosh here.
MedCrunch featured venture capital incubator Rock Health, a seed accelerator for health apps. The spot describes Rock Health as a welcomed alternative to the “chunky venture capital firms or other institutional investors.” The program is dedicated to entrepreneurs who want to build applications or products that are dedicated to solving health-related issues - Sound familiar?
Health 2.0 Developer Challenges